Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban treatment adjustment in aspirin- or clopidogrel-resistant patients undergoing PCI
2007-002427-32Phase 2Active
- Sponsor
- University of Ferrara
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tirofiban in coronary arteriosclerosis (2 arms), sponsored by University of Ferrara. Primary endpoint: Periprocedural necrosis after PCI. Started Mar 2008; status: active.
02
Drugs
tirofiban
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-002427-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002427-32.